Ticker Details
Natera, Inc. Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity.
IPO Date:	July 2, 2015
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$47.86B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.66 | 2.59%
Avg Daily Range (30 D):	$6.51 | 2.31%
Avg Daily Range (90 D):	$6.34 | 2.67%

Institutional Daily Volume
Avg Daily Volume:	.77M
Avg Daily Volume (30 D):	1.07M
Avg Daily Volume (90 D):	1.22M

Trade Size
Avg Trade Size (Sh.):	61
Avg Trade Size (Sh.) (30 D):	40
Avg Trade Size (Sh.) (90 D):	44

Institutional Trades
Total Institutional Trades:	7,774
Avg Institutional Trade:	$6.1M
Avg Institutional Trade (30 D):	$19.11M
Avg Institutional Trade (90 D):	$16.65M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$13.09M
Avg Closing Trade (30 D):	$38.37M
Avg Closing Trade (90 D):	$43.42M
Avg Closing Volume:	131.18K

News

Aug 8, 2026 @ 6:15 PM Stanley Druckenmiller's Portfolio Skips Megacap Te... Source: Dave Kovaleski

Apr 14, 2026 @ 6:30 PM Natera Positioned To Capture Growing $20 Billion M... Source: Vandana Singh

Mar 31, 2026 @ 4:48 PM Natera's Signatera Data Suggests Select Breast Can... Source: Vandana Singh

Feb 28, 2026 @ 9:37 AM 3 Reasons Exelixis Stock Could Deliver Marketâ€... Source: James Halley

Feb 22, 2026 @ 12:30 AM Billionaire Stanley Druckenmiller Is Betting Big o... Source: Lee Samaha

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.35	$-.47	$-.6
Diluted EPS	$-1.35	$-.47	$-.6
Revenue	$2.71B	$752.75M	$696.64M
Gross Profit
Net Income / Loss	$-192.35M	$-66.97M	$-85.09M
Operating Income / Loss	$-289.67M	$-75.79M	$-93.52M
Cost of Revenue
Net Cash Flow	$91.48M	$3.57M	$11.79M
PE Ratio